Concepedia

Amarnath Natarajan

AN

75

Publications

3K

Citations

31

H-Index

2000

Active since

Affiliations

University of Nebraska Medical Center(Current)

The University of Texas Medical Branch at Galveston

Nebraska Medical Center

Harvard University

Brigham and Women's Hospital

Amarnath Natarajan is an author at University of Nebraska Medical Center specializing in medicine, natural sciences, and pharmacology.

ORCID

Top concepts

Publications per year

2000–2024

75

Publications

75

Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)

Caroline M. Robb, Jacob I. Contreras, Smit Kour et al. · Chemical Communications · 2017 · 206 citations · Full text

Impact of structurally modifying hyaluronic acid on CD44 interaction

Deep Bhattacharya, Denis Svechkarev, Joshua J. Souchek et al. · Journal of Materials Chemistry B · 2017 · 194 citations

Novel Arylsulfoanilide−Oxindole Hybrid as an Anticancer Agent That Inhibits Translation Initiation

Amarnath Natarajan, Yuhong Guo, Frederick Harbinski et al. · Journal of Medicinal Chemistry · 2004 · 185 citations

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy

Yogesh A. Sonawane, Margaret Taylor, John V. Napoleon et al. · Journal of Medicinal Chemistry · 2016 · 149 citations · Full text

, , +17

Selective degradation of CDK6 by a palbociclib based PROTAC

Sandeep Rana, Mourad Bendjennat, Smit Kour et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 128 citations · Full text

, , +4

Rows per page

1–5 of 75